| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |